Dietary Human Milk Oligosaccharides but Not Prebiotic Oligosaccharides Increase Circulating Natural Killer Cell and Mesenteric Lymph Node Memory T Cell Populations in Noninfected and Rotavirus-Infected Neonatal Piglets. 2017

Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
Food Science and Human Nutrition and.

Background: Human milk oligosaccharides (HMOs) have antimicrobial and immunomodulatory actions. It has previously been reported that these oligosaccharides contribute to the reduced duration of rotavirus-induced diarrhea in pigs.Objective: We measured the effects of HMOs and prebiotic oligosaccharides on immune cell populations from noninfected and rotavirus-infected pigs. We hypothesized that dietary HMOs would modulate systemic and gastrointestinal immunity.Methods: Colostrum-deprived newborn pigs were fed formula, formula with 4 g HMOs/L (2'-fucosyllactose, lacto-N-neotetraose, 6'-sialyllactose, 3'-sialyllactose, and free sialic acid), or formula with 3.6 g short-chain galactooligosaccharides/L and 0.4 g long-chain fructooligosaccharides/L. On day 10, half of the pigs were infected with the porcine rotavirus strain OSU. Peripheral blood mononuclear cell (PBMC), mesenteric lymph node (MLN), and ileal Peyer's patch immune cell populations were assessed with the use of flow cytometry 5 d postinfection. Interferon-γ (IFN-γ)-producing cells were assessed with the use of Enzyme-Linked ImmunoSpot assay.Results: Infection changed immune cell populations with more systemic natural killer (NK) cells, memory effector T cells, and major histocompatibility complex II+ cells in infected than noninfected pigs (P < 0.06). Regardless of infection status, HMO-fed pigs had nearly twice as many PBMC NK cells, 36% more MLN effector memory T cells, and 5 times more PBMC basophils than formula-fed pigs (P < 0.04). These populations were intermediate in pigs fed prebiotics. PBMCs from HMO-fed noninfected pigs had twice as many IFN-γ-producing cells as did those from formula-fed noninfected pigs (P = 0.017). The PBMCs and MLNs of formula-fed noninfected pigs had 3 times more plasmacytoid dendritic cells (pDCs) than those of HMO-fed noninfected and formula-fed infected pigs (P < 0.04). In the MLNs, the formula-fed noninfected pigs had more macrophages, pDCs, and mature DCs (P < 0.04) but fewer immature DCs than HMO-fed noninfected pigs (P = 0.022).Conclusions: Dietary HMOs were more effective than prebiotics in altering systemic and gastrointestinal immune cells in pigs. These altered immune cell populations may mediate the effects of dietary HMOs on rotavirus infection susceptibility.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007223 Infant A child between 1 and 23 months of age. Infants
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008643 Mesentery A layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves. Mesenteries
D008895 Milk, Human Milk that is produced by HUMAN MAMMARY GLANDS. Breast Milk,Human Milk,Milk, Breast

Related Publications

Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
July 1985, Clinical and experimental immunology,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
January 2016, Frontiers in immunology,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
November 2018, Nature communications,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
November 2008, British journal of haematology,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
January 2006, Cytokine,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
December 2000, The Journal of investigative dermatology,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
February 2023, Immune network,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
April 2001, Experimental hematology,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
October 2005, Journal of neuroimmunology,
Sarah S Comstock, and Min Li, and Mei Wang, and Marcia H Monaco, and Theresa B Kuhlenschmidt, and Mark S Kuhlenschmidt, and Sharon M Donovan
March 2011, The Journal of nutrition,
Copied contents to your clipboard!